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COMPREHENSIVE ANALYSIS OF 20 CASES OF                      
SYSTEMIC SCLEROSIS 
Aim -  To study the epidemiological features, occupational risk factors and 
skin and systemic manifestations of Systemic sclerosis.  
Methods –  20 Patients who presented to the outpatient department fulfilling 
ARA criteria for Systemic sclerosis were enrolled. A detailed history  and 
thorough examination was done. Investigations including complete blood 
count, ESR, renal function tests,  blood sugar, liver function tests,  urine 
routine, X-ray chest PA view, HRCT – chest, Pulmonary function test,                   
ultrasound of abdomen and pelvis,  ECG, ECHO cardiogram, Barium 
Swallow, upper GI scopy, X ray of both hands were done for all the cases. 
Results – Female to male ratio was 5.7:1.  95% of cases were in the age 
group 21 -60 years. Occupational exposure to silica, solvents, pesticides and 
firework were present in 11 cases. Skin tightness (100%),  Raynaud’s 
phenomenon (65%), stellate scars (90%), Round finger pad sign (85%), 
gangrene (10%),nek sign (80%),  salt and pepper pigmentation (95%), 
generalized hyperpigmentation (45%), nail changes (70%) were noted. One 
case of mixed connective tissue disease and one case with overlap of 
Epidermolysis Bullosa Acquisita  were recorded. 
 Systemic involvement, gastroesophageal reflux (85%), Interstitial lung 
disease (95%), pulmonary arterial hypertension (5%), acral osteolysis (75%) 
was present. 
Conclusion – Female preponderance was noted. Occupational exposure was 
present in more than half of the patients. Even though skin involvement was 
present in all cases, 20% of cases presented only after systemic involvement. 
All the patients had diffuse involvement of skin. Only 65%  patients had  
Raynaud’s phenomenon, this is probably because of higher temperature 
present throughout the year in South India. Systemic involvement was seen 
in most cases, mainly involving the pulmonary, gastrointestinal system. 
Interstitial lung disease was present in 95% cases. No patient had renal 
involvement. 
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                                              INTRODUCTION 
Systemic sclerosis is a rare multisystem connective tissue disorder 
affecting the skin  and internal organs. It is characterized by connective 
tissue sclerosis, atrophy, vascular  abnormalities and autoantibodies.  
Female preponderance is present with peak age of onset in fourth decade.  
Systemic involvement includes interstitial lung disease, pulmonary arterial 
hypertension, cardiac involvement, dysphagia, gastroesophageal reflux, 
gastrointestinal involvement,  renal failure, malignant hypertension,  
muscle weakness, joint pain, bone involvement,  calcinosis. 
Diagnosis is made clinically and investigations are carried out to evaluate 
the systemic  involvement, its extent and monitoring. It is broadly 
classified into two groups; limited and diffuse cutaneous systemic sclerosis 
based on  the extent of skin involvement and systemic associations. 
Systemic sclerosis may be associated with other connective tissue 
disorders like Systemic Lupus Erythematosus, Dermatomyositis, Sjogren’s 
syndrome, Rheumatoid arthriris, polyarthritis. Treatment includes systemic 
steroids, cyclophosphomide, vasodilators and treatment of specific 
systemic involvement. 
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REVIEW OF LITERATURE 
SYNONYMS 
Progressive Systemic Sclerosis 
Systemic Scleroderma 
Acrosclerosis 
LITERAL MEANING 
The word “scleroderma” has its origin from Greek;  “sclero” means hard  
and “derma” means skin. The term Progressive systemic sclerosis  is 
better avoided because of variable course of the disease. 
HISTORICAL ASPECTS 
Hippocrates was first  to  describe  this  condition  as thickened  skin1.  
Scleroderma was then described in 1753 in a 17-year-old woman from 
Naples by  Carlo  Curzio1. In 1847 the term ‘Sclerodermie’ was coined by 
Gintrac2. A.J. Maurice Raynaud described Raynaud’s phenomenon in 
1862, and in 1871 he described its association with Systemic sclerosis3. 
Sir William Osler 4 gave the most vivid description of disease in 1898 - 
"In its more aggravated forms diffuse scleroderma is one of the most 
terrible of all human ills. Like Tithoneus to 'wither slowly’,  and like him 
to be beaten down and marred and wasted  until one is literally a mummy, 
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encased in an ever shrinking, slowly contracting skin of steel, is a fate not 
pictured in any tragedy, ancient or modern" . It was in 1945 visceral 
involvement became an accepted complication and the term Progressive 
Systemic sclerosis was coined by Goetz1. Later the word progressive was 
omitted as the disease has a variable course. Matsui described the typical 
histopathological changes of scleroderma in 1924. O’Leary and Nomland 
elaborated the distinctive features of Systemic sclerosis versus Morphea 
in an extensive clinical study in 19305. 
DEFINITION 
Systemic sclerosis is a multisystem disease  characterized by 
1. autoantibodies 
2. vascular abnormalities 
3. connective tissue sclerosis  
4. atrophy  
DIAGNOSTIC CRITERIA  
American College of Rheumatology (ACR, formerly American 
Rheumatism Association)  Subcommittee for Scleroderma have 
established the diagnostic criteria for Systemic Sclerosis, according to 
which patient should have one major criterion or two out of three minor 
criteria 6 
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A. Major criterion 
Proximal scleroderma: Symmetric thickening, tightening, and induration 
of the skin of the fingers and the skin proximal to the 
metacarpophalangeal or metatarsophalangeal joints, affecting limbs, face, 
neck or trunk 
B. Minor criteria 
1. Sclerodactyly 
2. Digital pitting scars  
3. Bibasilar pulmonary fibrosis 
This criteria is 97% sensitive and 98% specific for the diagnosis. 
The ACR has proposed an expanded list of criteria, 
including: 
1. Skin changes which include tightness, thickening, and nonpitting 
induration, sclerodactyly, proximal scleroderma; changes proximal to the 
metacarpophalangeal or metatarsophalangeal joints, and affecting other 
parts of extremities, face, neck, chest, abdomen, digital pitting, loss of 
substance from  finger pad, bilateral firm but pitting finger or hand 
edema, abnormal skin pigmentation (salt and pepper pigmentation).The 
changes are usually bilateral, symmetrical and almost always include 
sclerodactyly. 
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2. Raynaud’s  phenomenon: at least two-phase color change in fingers 
and often toes consisting of pallor, cyanosis, and reactive hyperemia. 
3. Visceral manifestations: bibasilar pulmonary fibrosis not attributable to 
primary lung disease, lower (distal) esophageal dysmotility, colonic 
sacculations 
 
CLASSIFICATION  
Patients are classified as 7 
i) diffuse cutaneous systemic sclerosis (dSSc) 
ii)  limited cutaneous systemic sclerosis (lSSc) 
Diffuse cutaneous systemic sclerosis 
 Short interval (<1 year) between the onset of Raynaud’s 
phenomenon and the development of skin changes 
 Peripheral and truncal skin involvement 
 Tendon friction rub 
 Pulmonary fibrosis, renal, gastrointestinal and myocardial 
involvement 
 Capillary drop-outs in nail folds 
 Anti Scl-70  - positive 
 Anticentromere antibody (ACA)  - negative 
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Limited cutaneous systemic sclerosis 
 Long history ( 1 yr duration ) of  Raynaud’s phenomenon 
 Only peripheral  skin involvement  
 Calcification, telangiectasia, late onset of pulmonary  arterial 
hypertension 
 Capillary dilatation  in nail folds 
 Anticentromere antibody( ACA)  - positive 
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EPIDEMIOLOGY 
Systemic sclerosis is a connective tissue disease with worldwide 
distribution and affects all races. Incidence varies between 2.3 and 10 per 
million population8. The prevalence rates according to a British study 
were 13 and 48 per million males and females respectively9.  Estimates of 
prevalence  in South Carolina are higher (67–265 per lakh population)10.  
The incidence and prevalence in the US are approximately 20 and 250 
cases per million population, respectively. 
              Women are affected more often than men. Ratio of males to 
females is between 1: 3 and 611. In men,  a number of occupational 
associations have been reported, especially miners and stonemasons12. 
This suggests pneumoconiosis and silicosis could be predisposing factors 
for Systemic sclerosis. 
               Age of onset in women peaks at fourth decade and  but in men it 
is still later. 85% of patients  with Systemic sclerosis are between the ages 
of 20 and 60 years.  Systemic sclerosis can occur in children and elderly.  
               Black patients have an earlier mean age of onset and more 
likelihood for diffuse disease14.                   
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           Approximately 1.5%  patients have one or more affected first-
degree relatives. This represents  a 10- to 15-fold higher risk of  Systemic 
sclerosis  in family members than in the general population. This  
supports the role of  genetics in disease pathogenesis. 
             Parameters predicting  a worse prognosis include male sex, black 
race, onset at older age, systemic involvement at the time of diagnosis, 
skin fibrosis involving the trunk, and elevated ESR. 
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ETIOLOGY  
Etiology of the disease is unknown.  And hence several etiological factors 
have been  hypothesized. 
Genetic factors 
Familial cases of Systemic sclerosis is rare. Less than 5 % concordance is 
seen in twin studies. But the incidence of antinuclear antibodies among 
family members is high suggesting the possibility of genetic role in 
pathogenesis of the disease13. 
HLA-DR typing show an increase in HLA  DR2, DR3 and DR5. The 
presence of HLA  B8-DR3-DR52-DQB2 haplotype  predisposes to                            
pulmonary involvement, interstitial lung disease.  Raised DR2 and DR5 
was seen in patients with mild disease and presence of anticentromere 
antibodies. 
Genetic polymorphisms of the candidate genes –  POLR3A, CXCR2,      
TGF β, SPARC, ACE, fibrillin 1, COL1A2 have been identified. 
There is increased frequency of microchimerism in Systemic sclerosis 
patients16. Microchimerism occurs due to transfer of fetal cells to the 
mother or  maternal cells to the fetus. This might trigger autoimmunity. 
Female preponderance suggest that the genotype involved is a dominantly 
inherited allele present in the X chromosome.  
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Age of onset depends on the time of occurrence of specific random events 
that is  possibly the somatic mutations in lymphoid stem cells. This leads 
to production of  ‘forbidden’ clones. The forbidden clones produce  
autoantibodies which are pathogenic and  damage the endothelial cells. 
After a latent period, damage occurs  to the  tissues occur.   
Immunological factors 
Antinuclear antibodies is present in over 80% of patients. Anti-
topoisomerase I antibodies is seen in 22% of patients and anticentromere 
antibodies in up to 30% of patients. 
   Anti-RNA polymerase III antibody is associated with renal crisis in 
about 20 % of cases. U1 RNP antibody is seen in overlap syndrome – 
mixed connective tissue disorder. 
These facts suggest the possibility of autoimmune mechanism. But it is 
not yet clear if antibodies are the primary abnormality or they result from 
cellular damage.  
Environmental factors 
Several substances have been identified as risk factors involved in the 
causation of the disease. It is found in the studies that men are at higher 
risk of acquisition of scleroderma following occupational exposure. 
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 Silica –the most commonly implicated substance which is  found in 
the earth and several other products. But it is the inhalation of 
crystalline silica which causes autoimmune disorders like Systemic 
sclerosis, SLE12. 
 Solvents like benzene, trichloroethylene, paint thinners and 
removers18 
 Polyvinylchloride17 
 Pesticides - heptochlor, malathion, parathion, DDT, sodium 
dinitro-orthocresolate and 7-chlorocyclohexane19 
 Dental amalgam containing mercury 
 Epoxy resins20 
 Firework  - heavy metals like Aluminium, Antimony, Barium, 
Copper, Iron, Magnesium, Lithium, Zinc, Gold 21 
Drugs 
Bleomycin22,  Carbidopa 23 ,  Paclitaxel , Cocaine25, pentazocine 24 have 
been implicated in causing scleroderma and Raynaud’s phenomenon. 
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PATHOGENESIS 
The key components involved in the pathogenesis are  
1. microvascular dysfunction and damage  
2. immune activation with autoantibody production 
3.  fibrosis of tissues 
Vascular 
 Vascular dysfunction and endothelial injury  represent early events in the 
pathogenesis of the disease. Vasculopathy is due to  
 Altered balance between  vasoconstrictors (e.g. endothelin) and 
vasodilators (e.g. nitric oxide)  
 endothelial cell apoptosis26 
 intimal proliferation progressing to luminal occlusion 
 defective angiogenesis 
 Resultant hypoxia leads to synthesis of profibrotic cytokines, fibroblast 
activation and collagen production.  
Raynaud's phenomenon is caused by both 
 reversible vasospasm  
  irreversible arterial damage -  intimal proliferation and luminal 
obstruction 
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Endothelial damage is reflected in abnormal capillary loops and avascular 
areas in the proximal nail folds as well as the development of 
telangiectasias. Endothelial injury lead to vascular leak and edema, which 
characterize the early oedema phase of cutaneous involvement. Vascular 
abnormalities   play a major role in the    pathogenesis    of  renal crisis 
and pulmonary hypertension. 
Fibrosis  
Stimulation of fibroblasts by  cytokines and growth factors lead to 
fibrosis of tissues27. TGF – β28 and CTGF 29 constantly stimulate the 
fibroblasts and result in  sustained production  of collagen. The fibroblast  
is hence in a profibrotic microenvironment.  
The accumulation of collagen in Systemic sclerosis  seems to be 
primarily the result of increased synthesis, rather than decreased 
degradation.   
Though there is no direct evidence of cytokines involved in fibrosis, it is 
possible that improvement may occur by inhibiting the cytokines. 
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Immune activation  
Factors favouring immunological role in Systemic sclerosis 
 The presence of autoantibodies supports a role for immune system 
activation  
 Topoisomerase I–antitopoisomerase I  complexes attached  to 
fibroblast  stimulate monocyte adhesion  
  antiendothelial  antibodies trigger endothelial cell apoptosis30 
 antibodies against PDGF  receptor  induce expression of type I 
collagen in fibroblasts 
 clonal T-cell expansion  seen in lesional skin indicates an antigen-
driven response 
 Lymphocytic infiltrates have been observed in the skin as well as 
the lungs  
 T cells show a predominant Th2  profile with increased secretion  
of profibrotic cytokines such as IL-4  
 Expansion of naive B cells and chronic activation, but  there is 
decreased number of memory B cells 
 Similar clinical features in  chronic GVHD.  
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It is clear from the above facts that immune system is affected. But 
immunosuppressive drugs have failed in producing  disease-modifying 
responses and this raises questions regarding its role. Perhaps 
immunologic events occur only in the early phase.
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CLINICAL FEATURES 
SKIN MANIFESTATIONS 
1.Skin tightness 
Skin undergoes three phase change 
 early edematous phase -  pitting edema of the digits  
 sclerotic phase - taut, shiny appearance, immovable or hidebound 
due to binding down of  skin to the  deeper structures 
 atrophic phase - gradual softening of the skin 
 
The hands and face are most commonly involved and extends proximally 
to involve the forearms and arms. The fingers become semiflexed, 
immobile and useless, the skin over  the fingers become hard, inelastic, 
palid and incompressible. Distal phalanges are boardlike and indurated.  
Mizutani described the “round finger pad sign”31. Due to loss of pulp on 
digit, fingers appear as rounded hemisphere rather than normal peaked 
contour when viewed from side. This is more appreciated in ring finger. 
This is not only seen in systemic sclerosis but also in MCTD, severe 
Raynaud’s phenomenon with sclerodactyly. 
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    Face is drawn, stretched and masklike with loss of lines of expression. 
Forehead is smooth, shiny and taut,   nose becomes sharp and pinched,  
mouth opening is restricted and radial furrows and thin lips  gives  a 
pursed mouth appearance. 
 Oral aperture becomes drastically reduced and interferes with eating and 
maintain oral hygiene.  The lower eyelids cannot be retracted  to visualize 
tarsal conjunctivae due to atrophy of the tissues. A. J. Barnett32 described         
“ neck sign” which is ridging and tightening seen on extension of neck. 
This is found in 90% of cases and  is due to adherence of skin  to the 
platysma which interfere with neck extension. 
             Chest is  tight, shiny and pigmented. Severe involvement leads to 
cuirasse like restraint of respiration. In feet, less severe changes occur, 
but not infrequently black toes with incipient gangrene occur. The feet 
becomes encased in tight, firm and taut skin with pigmentory changes and 
atrophy. The skin  changes can extend upto the thighs. Skin thickening  
and fibrosis adjacent to tendons lead to contractures at elbow, wrist and 
knees.  
              A very small group of patients develops vascular, immunologic, 
and organ-based fibrotic features of Systemic sclerosis without skin 
sclerosis. They constitute approximately 1 percent of Systemic sclerosis  
cases and are termed Systemic sclerosis sine scleroderma.  
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   The extent and severity of skin involvement  can be evaluated  by 
Modified Rodnan Skin Score (MRSS). Usually, 17 sites are assessed by 
palpation of the skin by a trained examiner and skin thickness is 
categorized to grade 1, 2, or 3, corresponding to mild, medium, and 
severe. Maximum skin score being 51. Skin score at baseline correlates 
with disease severity and outcome.             
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2. Raynaud’s  phenomenon 
 Raynaud's phenomenon is characterized by episodic vasospasm of the 
arteries of digits. In some patients it may affect the tip of nose and 
earlobes. Exposure to  cold, precipitates the attack; frequency and 
severity of attacks is more in winter.  Typical attack starts as pallor, 
followed by bluish discoloration. Eventually erythema occurs 
spontaneously or on rewarming. Pathogenetic mechanisms of colour 
change is vasoconstriction, ischemia, and reperfusion. Some experience 
only pallor or cyanosis.  Primary Raynaud’s phenomenon represents an 
exaggerated physiological response to cold and is not associated with 
underlying disease. Secondary  Raynaud’s phenomenon occurs with 
underlying connective tissue disorder, endocrine conditions, occupation 
involving vibratory tools, medications and malignancy. It is more severe, 
frequent, prolonged and painful and is associated with ischemic lesions 
and gangrene of digits. 
               It is the earliest symptom to appear in Systemic sclerosis.  
Raynaud’s phenomenon may be present for months or years before  the 
skin changes appear. The duration is shorter in males,  usually less than 
one year33. In females,  it is around  five years, but may be longer upto 
thirty years.  
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Raynaud’s  phenomenon can be absent, can occur simultaneously, or  
occur after the onset of skin changes.  In  Diffuse cutaneous systemic 
sclerosis, the interval between the onset of Raynaud’s phenomenon and 
skin changes is shorter, less than one year. In  Limited cutaneous 
systemic sclerosis the interval is longer. Sclerodactyly may be present in 
10% of cases with Raynaud’s disease, but the occurrence of  systemic 
sclerosis is rare.  Nail fold capillaroscopy and  autoantibody testing are 
helpful in differentiating Raynaud’s disease and systemic sclerosis34. 
 
3. Fingertip ulcers  
                     Small painful fingertip ulcers are common finding and 
difficult to treat. Ulcers are due to  ischemia, fibrotic tissue and trauma. 
Ulcers on the interphalangeal joints are likely to persist because of 
continued trauma. They  heal leaving behind depressed stellate scars.   
Pitted scars occur not only on the tips of the fingers but also on the ulnar 
border of  thumb,  radial borders of  index and middle fingers and  dorsa 
of the finger  joints.  Ulcers can lead to osteomyelitis  and 
autoamputation. They are painful and limit the use of the fingers and 
hands thereby  decreasing  the ability to perform activities of daily living 
and can lead to the depression. Gangrene of the digits is not uncommon 
and can occur  early in the disease. 
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4. Pigmentary changes  
Diffuse hyperpigmentation is the most common pigmentary change. 
Pigmentation occurs in about half of the patients, most common  site 
being  face and  less commonly present in  legs, thighs, lower abdomen, 
axilla. Patients appear to be tanned, and the hyperpigmentation is more 
pronounced in areas of pressure such as the belt line or under brassiere. 
Sometimes the pigmentation may be extensive and  lead to  the suspicion 
of Addison’s disease.  
The leukoderma is characterized by localized areas of depigmentation 
with sparing of the perifollicular skin; described  as the ‘salt and pepper’ 
sign. It is common in scalp, upper back and chest. Perifollicular 
pigmentation may appear in response to UV exposure. Pigment may also 
be retained in the skin overlying superficial veins ( perivenular retention 
of pigment). 
 
5. Nail changes 
Nail in later stages becomes very small and seen curving over the 
terminal phalange. The nail fold frequently shows ragged cuticles.   
Pterygium lnversum unguis may occur where the distal part of the nailbed 
is adherent to the ventral surface of the nail plate. Paronychia and Slow 
healing whitlows are common.  
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Dilated, nailfold capillary loops are present in 90% of systemic sclerosis 
patients34. Use of an ophthalmoscope or dermascope may enhance 
appreciation of the changes.  
In diffuse cutaneous Systemic sclerosis nail folds show capillary drop-
out. In limited cutaneous Systemic sclerosis nail folds show capillary 
dilatation. 
 The changes occur symmetrically in systemic sclerosis.  This 
differentiates it from the nailfold capillaries of the Osler-Weber- Rendu 
syndrome which typically have dilatation of only one half of the loop and 
no avascular areas. 
 Nailfold capillary hemorrhage in two or more fingers is highly specific 
for limited cutaneous Systemic sclerosis and correlates with the anti 
centromere antibody.  
 
6.Telengiectasia 
Telangiectasias are more common in patients with limited type Systemic 
sclerosis  but  can also occur in diffuse type Systemic sclerosis. Size 
varies  from 2 mm to 2 cm in diameter, blanches on pressure.  
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They are frequently found on the face, chest and hands. These 
telangiectatic macules are said to be matted or squared-off, which 
differentiates it  from the raised lesions associated with hereditary 
hemorrhagic telangiectasia. 
 
7. Calcinosis cutis 
Weber 35first described occurrence of calcinosis cutis in systemic 
sclerosis long  before Thibierge and Weissenbach36. Calcinosis is a late 
manifestation of  Systemic sclerosis and is common in  limited type.  
It made of calcium hydroxyapatite and can be found  in the fingertips,    
and muscles. This is usually present in cases with                           
dermatomyositis overlap.  
Calcinosis usually  seen at the areas prone for  trauma like the extensor 
surfaces of forearm and fingers. These calcifications  can ulcerate 
discharging chalky material and sometimes leading to secondary 
infection.  
  The pathogenesis is still  not clear, probably induced by tissue damage, 
hypoxia and physical trauma. Calcification can occur in the internal 
organs also. 
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Other skin changes 
 cobble stone appearance in skin – multiple small papules of 
telengiectasia occur due to lymphatic obstruction by sclerosing 
process 
 Hypohidrosis of skin leads to dryness of skin and pruritus can be 
marked. 
  Fibrotic skin shows diminished hair growth and  hypertrichosisis 
common in the recovery phase. 
 Vesicles and bullae may occur especially in distal extremities 
 Leg ulcers can occur and are slow healing and difficult to treat 
 Livedo reticularis 
 Atrophie blanche 
 Erythema nodosum like nodules 
 Hyperkeratotic plques over the phalanges 
 Erythema over thenar and hypothenar eminences 
 Chondrodermatitis nodularis helicis 
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OVERLAP SYNDROMES 
Group of disorders showing features of two or more autoimmune 
connective disorders 
 Systemic sclerosis 
 Polymyositis or dermatomyositis 
 Systemic lupus erythematosus 
 Sjögren syndrome 
 Vasculitis 
 Polyarthritis 
 Rheumatoid arthritis 
Some association occur more frequently than others. For instance, 
systemic sclerosis is more often associated with dermatomyositis than 
systemic lupus erythematosus. The disease can occur concurrently or 
consecutively. 
Recently antibody markers are being identified in these subsets with 
particular pattern of disease as mentioned below. Identification of 
antibodies and subsets not only provides information about prognosis and 
treatment but also provides clues for identifying antigen targets and about 
etiopathogenesis. 
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 anti-U1-ribonucleoprotein – mixed connective tissue disease  - 
systemic lupus erythematosus, systemic sclerosis or myositis 
 anti PM-Scl, anti Ku, U2-ribonucleoprotein  -  systemic sclerosis 
and polymyositis 
  anti-Jo-1  -  polymyositis and pulmonary fibrosis 
 
MIXED CONNECTIVE TISSUE DISEASE 
Sharp et al 37 in 1972 described in a group of patients with clinical 
features of SLE, Systemic sclerosis, myositis association with antibody to                    
U1 ribonucleoprotein (RNP). 
It is reported in all races and there is no difference in clinical presentation 
among various ethnic groups.   
More common in females, the ratio of male to female being 1:3.  Onset of 
disease can occur at any age, more commonly  between 15 and 25 years.  
Clinical features are Raynaud’s phenomenon, joint involvement,  
sclerodactyly,   oesophageal dysmotility,  myositis,  pulmonary 
hypertension, swelling of hands, malar rash, pleuritis and pericarditis. 
Renal involvement is present clinically in 5 % of cases.  
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Neuropsychiatric manifestations occur in about 15 % of cases and include 
trigeminal neuralgia, aseptic meningitis, transverse myelitis and 
psychosis. 
A study based on  large single-center cohort of MCTD patients suggests 
that  3 clinical subclusters of MCTD manifestations may exist38 
 Patients with predominant vascular manifestations, like Raynaud’s 
phenomenon, pulmonary hypertension  and antiphospholipid syndrome 
with thromboses.  These patients are at the greatest risk of mortality.  
 Patients with  polymyositis like picture, including interstitial lung 
disease, oesophageal dysmotility and myositis 
 Patients with erosive polyarthritis with antibodies to CCP (cyclic 
citrullinated  peptides) and sclerodactyly. 
MCTD is more severe in children, often with arthritis, renal, cardiac 
involvement.  Thrombocytopenia may be present in children. But the 
overall prognosis is quite good. 
 The disease responds well with corticosteroids. Other  treatment options 
include  hydroxychloroquine and methotrexate and have been reported to 
be successful. Prognosis is generally better than that of Systemic sclerosis.  
Antibody U1 RNP gets suppressed on treatment and disappears when the  
patient is in remission 39. 
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SYSTEMIC INVOLVEMENT 
GASTROINTESTINAL INVOLVEMENT  
                Gastrointestinal tract is involved in 90% of patients40. 
Underlying pathology – prominent atrophy and fibrosis of smooth 
muscle, obliterative vasoculopathy lead to abnormal motility of 
oesophagus, stomach and intestine.  
               Oesophagus  is the most frequently involved  part of the 
gastrointestinal tract affecting upto 75 % of the cases. Gastroesophageal 
reflux disease (GERD) starts early and presents with  heartburns, 
regurgitation of food and dysphagia. It is due to reduced lower 
oesophageal sphincter pressure, abnormal motility of lower two- third of 
the oesophagus and delayed emptying of stomach. Chronic GERD leads 
to complications like strictures, Barrett’s oesophagus and 
adenocarcinoma. Extra – oesophageal complications include hoarseness 
of voice, chronic cough and aspiration pneumonitis40. Dysphagia occurs 
due to loss of propulsive peristalsis, oesophagitis and candidial infection. 
Localized dysphagia involving the neck region can occur  because of 
thickened pharyngo- oesophageal muscles41. Oesophageal  aperistalsis  
and diffuse spasm have been reported. 
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                  Stomach is rarely involved in about 6 % of cases, in Asians 
the incidence is higher. Gastroparesis causes early satiety, abdominal 
distension and pain, and aggravates GERD.  Telengiectasia can occur 
throughout the GIT and can cause bleeding. Gastric antral vascular 
ectasia are subepithelial lesions and may cause recurrent occult bleeing 
leading to anaemia. Endoscopy shows striped appearance and hence 
called watermelon stomach. 
               Small intestinal dysmotility results in stagnation of food 
eventually leading to bacterial overgrowth causing diarrhea and 
malabsorption. Malabsorption of fat, protein, calcium, folic acid and 
vitamin B12 ensue, sometimes leading to severe malnutrition. This can be 
treated with tetracyclines. Disturbed intestinal motor function also causes 
pseudoobstruction of the intestines. Clinical features include acute 
abdominal pain, nausea and vomiting. Diagnostic challenge in 
distinguishing it  from true obstruction. Pseudobstruction responds to 
supportive care and intravenous nutrition. Pneumatosis cystoides 
intestinalis  occur due to air trapping in bowel wall42. Cysts can rupture  
resulting in  pneumoperitoneum. Pancreatic necrosis and  volvulus can 
rarely occur. Colon involvement can cause constipation, diarrhea, rectal 
prolapse, volvulus. Wide mouth diverticula can rarely perforate or bleed. 
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PULMONARY INVOLVEMENT 
Respiratory symptoms in scleroderma lung disease can be quite 
nonspecific. The fact that the pulmonary manifestations are the leading 
cause of morbidity and mortality prompts the efforts to detect the 
respiratory involvement as early as possible 44. The precise staging and 
the timely institution of therapy influence the outcomes of scleroderma. 
Dyspnea on exertion  is the symptom usually first noticed, but with 
progression it is also present at rest. The cough is often dry and 
nonproductive. The tightness of chest is often reported, along with some 
nonspecific symptoms like fatigue. 
Dyspnea could be due to ILD or due to some infrequent pulmonary 
manifestations, such as bronchiectasis/bronchioloectasis, diffuse alveolar 
hemorrhage. Sometimes the causes may be extrapulmonary like cardiac 
involvement, especially the left ventricular diastolic dysfunction, 
diminished thoracic cage expansions, neuromuscular, and pleural disease.  
The involvement of the lungs in scleroderma may be detected by 
auscultation, as in some patients the bibasilar late inspiratory fine 
crackles are identified. Physical examination reveal loud P2, and ejection  
systolic murmur over  left sternal border. Tricuspid regurgitation, 
hepatomegaly, ascites, and edema are signs of corpulmonale.   
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 ILD is most frequent among pulmonary manifestations. Though 
pulmonary fibrosis is more associated with Diffuse cutaneous 
scleroderma, it can  occur in limited cutaneous forms and scleroderma 
sine scleroderma. 
 Pulmonary arterial hypertension 
Incidence is about 8 – 10 % in scleroderma patients 44. Although it occur 
in both limited and diffuse cutaneous subsets, the most cases are of 
limited cutaneous Systemic sclerosis.  This condition has features similar 
to idiopathic PAH.  
 Two patterns of pulmonary hypertension occur in Systemic sclerosis. 
1. primary PAH  
2. secondary Pulmonary Hypertension – seen in late-stage extensive 
interstitial lung fibrosis, they develop a true secondary PH. 
It is important to distinguish both as fibrosis is also present in cases of 
PAH. If lung volume is less than 60% of the predicted value, pulmonary 
hypertension is more likely to be secondary to pulmonary fibrosis. 
 Exertional dyspnoea is the main symptom. Fatigue, chest pain and edema 
are features of right heart failure. Prognosis was worse pretreatment era. 
The three year survival rate is around 30 %. But the prognosis of PAH 
due to Systemic sclerosis is better than idiopathic PAH.  
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RENAL INVOLVEMENT 
Most frequent findings include chronic nonprogressive proteinuria and 
hypertension. The most dreaded complication, scleroderma renal crisis  
occurs in 20% of patients. The pathogenesis involves obliterative 
vasculopathy of renal cortical arteries leading to reduction in blood flow. 
This is aggravated by vasospasm leading to activation of renin 
angiotensin axis and further vasoconstriction cycle resulting in malignant 
hypertension. Precipitating factors include dehydration and hypotension. 
Risk factors are male, diffuse involvement, African – American race 46.  
Patients with malignant hypertension present with sudden onset of severe 
headache, blurring of vision, chest pain. In 10 % cases, blood pressure 
remains normal, this is described as normotensive renal crisis. Urine 
examination shows proteinuria, hematuria. Peripheral blood smear shows 
thrombocytopenia and fragmented RBCs. 
Aggressive management with ACE inhibitors improve the prognosis 45. 
CARDIAC INVOLVEMENT 
Scleroderma can involve all structures, endocardium, myocardium, 
pericardium individually or together. Cardiac involvement is often silent 
but can be detected by sensitive diagnostic tools.  
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Cardiac involvement is more common in diffuse cutaneous systemic 
sclerosis 43. Manifestations include 
 Pericardial effusion 
 Conduction abnormalities 
 Rhythm abnormalities  - Atrial & ventricular tachycardia 
 Pulmonary arterial hypertension  
 Mitral valve prolapse 
 Cardiac failure 
 Valvular regurgitation  
 Hypertrophic cardiomyopathy 
Cardiac involvement develops early in the disease usually within three 
years of onset of skin thickening. Clinically evident cardiac involvement 
has poor prognosis. 
 
BONE INVOLVEMENT 
Acroosteolysis (i.e. resorption of the distal end of the phalanx) may occur 
due to long-standing digital ischemia. Sometimes it affects other sites, 
including the mandibular condyles, the distal radius, and the superior 
portion of the posterior ribs. In scleroderma, acral osteolysis can occur 
with calcinosis, this differentiates it from Raynaud’s phenomenon where 
only acral osteolysis occurs47.   
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Other bone changes in scleroderma include juxta-articular osteoporosis, 
osteopoikilosis48, and avascular necrosis of the femoral head.  
 
MUSCLE INVOLVEMENT  
Myopathy can occur in two different forms49 
 Noninflammatory fibrotic myopathy (60%–80%) - characterized 
by mild weakness and a minimally elevated creatine kinase 
 Inflammatory myositis (6%–12%)  - elevated levels of serum 
creatine kinase and aldolase, and PM-Scl antibodies, 
indistinguishable from polymyositis.  
The muscles of the forearms and hands are involved as well as the 
proximal muscles.  
The juxta-articular tendons of the fingers, forearms, legs, and neck can be 
altered by fibrosis causing audible friction rubs as the tendon is moved 
actively or passively.  
JOINT INVOLVEMENT  
Generalized arthralgias and morning stiffness affecting both small and 
large joints often precedes skin changes. In diffuse scleroderma, rapid 
development of hand swelling and sclerotic changes can lead to severe 
flexion contractures with claw-like hand deformities and                    
severe disability. 
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CENTRAL NERVOUS SYSTEM  
Involvement is seen in around 10% patients. Manifestations 50 include 
 Trigeminal neuropathy occurs in 4% of patients. It presents with  
pain and numbness over the face.  It is initially unilateral, later  
becomes bilateral.  
 Brachial plexopathy 
 Carpal tunnel syndrome  
 Meralgia paraesthetica 
 Lumbosacral radiculopathy  
 Subacute combined degeneration due to deficiency of  vitamin B12  
 Spinal cord compression as a result of soft-tissue calcification. 
 Prolongation of sensory chronaxia - both abnormal and normal 
skin.  
 Duration of action of local anaesthetics is prolonged 
  
DENTAL CHANGES 
Stafne’s sign - Widening of the periodontal membrane is present   in 
about  30% of patients51. It is not a diagnostic sign  as it  is also                
seen in periapical infection. In periapical infection, it is present                
in   only   one   teeth. 
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EYE INVOLVEMENT  
Eyes changes 52 include 
 Tightness of the eyelids 
  Shallow fornices  
 Diminished tear secretion 
  Keratoconjunctivitis sicca  
 Retinopathy – due to direct vascular involvement 
Sjögren’s syndrome is seen  in 15% of cases. 
 
GENITAL TRACT INVOLVEMENT 
 
Dryness of vagina, ulcers lead to painful intercourse and decreased sexual 
satisfaction 53. This often results in decreased frequency of intercourse. 
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CHILDHOOD SYSTEMIC SCLEROSIS 
 
 Systemic sclerosis  is rare in children,they make up only 3% of all cases 
of scleroderma. Clinical features resemble those of  adults. However 
Raynaud’s phenomenon, dilatation of nailfold capillary, digital ulcers,    
pitting scars, and telangiectasia are less frequently seen.   
The course in childhood is slower and  systemic involvement is less 
severe. Renal involvement is  rare 54. 
  Pulmonary disease is almost universal in children with Systemic 
sclerosis and High resolution CT scanning is  sensitive and appropriate 
for younger children who cannot perform pulmonary function tests. 
Because early aggressive treatment may improve the outcome,  patients 
with pulmonary disease, high resolution CT scanning should be 
performed in patients and should be monitored annually for its 
development. 
Symptoms of gastrointestinal reflux (GERD) and oesophagitis may not be 
reported by children.  Therefore children  may need to  be evaluated for 
acid reflux even in the absence of clinical symptoms. 
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In childhood Systemic Sclerosis,  ANA is positive in 22% to 100% of 
patients, and anti-Scl 70 positive in approximately 40% of patients. 
Antibodies to centromere are uncommon, this reflects  the rarity of 
limited type disease in children 
 
Systemic sclerosis in Pregnancy  
 
 Systemic sclerosis generally remains unchanged throughout the 
course of pregnancy, but reports of postpartum renal failure and 
gangrene are present.  
 Severe pulmonary,  renal  or cardiac disease may be an indication 
for termination of  pregnancy. Complications are common in late 
pregnancy55. 
 ACE - Angiotensin Converting Enzyme inhibitors is helpful for 
treating hypertension, but  this carries potential risk to the fetus.  
 Fertility may be impaired. 
 
 
 
 
39 
 
 
DIFFERENTIAL DIAGNOSIS  –  SCLERODERMOID 
CONDITIONS 
The differential diagnosis of dermal sclerosis is extensive. Systemic 
sclerosis is  distinguished by the characteristic symmetrical  induration of 
the skin of  distal extremities (especially the upper extremity), nailfold 
capillary changes,  Raynaud's phenomenon, autoantibody profile  and 
internal organ involvement. 
Immunological  
Morphea 
Eosinophilic fasciitis  
Chronic GVHD 
Metabolic 
Diabetic cheiroarthropathy 
Porphyria cutanea tarda 
Phenylketonuria 
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GEMSS syndrome – glaucoma, Ectopia lentis , Microspherophakia, Stiff 
joints and Short stature syndrome 
 Mucinosis 
Scleredema 
Scleromyxoedema 
Toxin mediated 
Nephrogenic systemic fibrosis 
Toxic oil syndrome 
Eosinophilia myalgia syndrome 
Drug or chemical 
Bleomycin, carbidopa, pentazocine, cocaine, Taxanes 
Vinyl chloride, chlorinated hydrocarbons, benzene, toluene, epoxy resins 
Venous insufficiency 
Lipodermatosclerosis 
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Genetic  
Hutchinson – Gilford syndrome 
Werner Syndrome 
Stiff skin syndrome 
Huriez syndrome 
Ataxia telangiectasia  
Neurological 
Reflex sympathetic dystrophy 
Spinal cord injury 
Paraneoplastic  
POEMS syndrome 
Primary amyloidosis 
Carcinoid syndrome 
Neoplastic  
Carcinoma en cuirasse 
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INVESTIGATIONS 
 Acute-phase reactants 
 –  is raised if patient has synovitis, tendon friction rub, arthritis 
 Complete blood count 
- Anaemia 
1.  iron deficiency anaemia – due to recurrent Gastrointestinal 
bleeding 
2. Anaemia of chronic disease 
3. Vitamin B12/ folic acid deficiency – caused by 
malabsorption due to hypomotility and bacterial overgrowth 
4. Microangiopathic hemolytic anemia – fragmented RBCs 
seen  in  scleroderma renal crisis46 
 
AUTOANTIBODIES 
 Antinuclear antibodies is positive in 80 –90% of patients with Systemic 
sclerosis. It is still not clear whether antibodies have a direct role in 
pathogenesis or they are occur as  an epiphenomenon.  
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The antibodies classically associated with Systemic sclerosis 57are 
- ACA (Anticenteromere antibodies)    
- antitopoisomerase I or anti-Scl-70. 
 ACA is seen in limited cutaneous Systemic sclerosis and 
antitopoisomerase I is seen in diffuse cutaneous Sytemic sclerosis.  
 
 Less commonly  associated antibodies – disease specific57 
- anti-PML-Scl 
- anti-Th/To 
-  antifibrillarin /anti-U3 ribonucleoprotein 
-  anti-RNA polymerase  
 
less commonly associated antibodies – disease nonspecific57 
- anti-Ku 
- anti-Ro 
-  antiphospholipid 
- anti-U1RNP  
- anti-Sm antibodies  
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Anticentromere Antibody 
The Anticenteromere antibodies 57 is positive  in 20  to 30 % of  patients 
with Systemic sclerosis. They are present  in  around  50% of patients 
with the limited type of Systemic sclerosis, but in less than 5% of patients 
with the diffuse form of disease. They are strongly associated with the 
CREST syndrome (calcinosis, Raynaud’s phenomenon, esophageal 
dysmotility, sclerodactly and telangiectasia). When found in patients with 
Raynaud’s phenomenon they predict the development of Systemic 
sclerosis. The presence of Anticenteromere antibodies  carries a better 
prognosis. 
Antitopoisomerase-I Antibodies (Anti-Scl-70 Antibodies) 
 They are seen in up to 40% of patients with diffuse cutaneous Systemic 
sclerosis and less than 10% of patients with limited cutaneous Systemic 
sclerosis 57. 
When present in a patient with Raynaud’s phenomenon, they predict the 
risk of developing Systemic sclerosis. Anti-Scl-70 antibodies are 
associated with interstitial lung disease (ILD). 
ACA and anti-Scl 70 exist in isolation and are rarely found together 
 
45 
 
Antinucleolar Antibodies  
 Anti-PM-Scl antibodies 57 
 – 50% of cases with polymyositis/scleroderma overlap 
syndrome.  
                 -         2–3% of cases with Systemic sclerosis       
  -        8% of cases with myositis. 
 Anti-Th/To antibodies57 
Antibodies  are directed against the ribonuclease mitochondrial 
RNA processing complex (MRP) and ribonuclease P 
complexes.  
They are found  in about  2–5% of patients with Systemic 
sclerosis and show racial difference being  more commonly 
found in Japanese patients. They have also been seen in 
patients with SLE and PM. Similar to Anticenteromere 
antibodies  they indicate limited type disease.  
 The anti-RNA polymerase group (I and III) – 20 % 
Associated with diffuse type of Systemic sclerosis and  
correlates with pulmonary arterial hypertension (PAH).  
 Antifibrillarin antibodies 57 -  4%  diffuse type of disease with 
myositis, PAH and renal involvement. 
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Other Autoantibodies 
 Anti-Ku antibodies -  Overlap syndrome - SLE and systemic 
sclerosis 
 Anti-Ro antibodies - Systemic sclerosis with Sjögren 
syndrome.  
 Anti-Sm antibodies – Systemic sclerosis with  features of SLE 
and  renal involvement. 
  Anti-U1-RNP antibodies – Mixed connective tissue disease 
(MCTD) – features of Systemic sclerosis, SLE, 
dermatomyositis. They have a favourable prognosis 
  Anticardiolipin antibodies are present in  about 20–25% of 
patients  
SKIN BIOPSY 
Skin biopsy is  not routinely done and is rarely indicated as the diagnosis 
is made clinically based on the ACR criteria 
It may be of  help  in atypical presentations of disease and in 
differentiating from conditions mimicking Systemic sclerosis. 
Histopathology of morphea and systemic sclerosis are identical and is not 
possible to differentiate both histolgically. 
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 Biopsy shows a thinned epidermis and extensive fibrosis of the lower 
two-thirds of the dermis and extending into the panniculus, replacing the 
subcutaneous fat. A perivascular mononuclear cell infiltrate may precede 
fibrosis. The collagen bundles appear pale, homogeneous and swollen. In 
later stages, a significant inflammatory cell infiltrate is not observed; this 
is in contrast to morphea, where a prominent inflammatory cell 
infiltrate is present. The number of adnexal structures is reduced, 
another characteristic feature, and the epidermal rete ridges are 
effaced 58. 
Direct immunofluorescence is usually negative in Scleroderma.  
 Pulmonary Function Tests : 
Pulmonary function tests  play a  crucial role in evaluation of pulmonary 
involvement in scleroderma.  
Up to 40% of  scleroderma patients show at least a moderate restrictive 
pattern in spirometry,  and 15% have severe restriction without 
obstruction. Diffusion capacity for carbon monoxide (DLCO) is more 
sensitive in detecting lung involvement than forced vital capacity (FVC), 
but less specific for ILD as pulmonary vascular disease and COPD 
emphysema may also cause decreased DLCO59.  
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Impaired DLCO correlates with severity of ILD, measured as the extent 
of the disease on computed tomography. Baseline values of DLCO and 
FVC have been used to measure disease severity. The decrease in both 
variables has been associated with increased mortality of patients with 
ILD in scleroderma. It is to note that disease severity in patients with 
pulmonary fibrosis due to scleroderma should be classified as mild, 
moderate, and severe when the measures of DLCO and FVC are 70-79%, 
50-60%, and less than 50% of the predicted values. Combination of 
normally preserved lung volumes and considerably decreased  DLCO is 
characteristic of presence of PAH. 
Imaging Studies 
Chest X-ray in scleroderma patients with ILD shows linear and  
reticular pattern, superimposed upon the ground-glass attenuation. 
Traction  
bronchiectasis may be detected, but contrary to the finding in idiopathic 
pulmonary fibrosis (IPF), the honeycombing is rare . Evidence of 
pulmonary disease  has been described in chest X-rays in 20–65% of 
patients affected by scleroderma. 
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 HRCT  has improved the diagnosis  of ILD due to its high sensitivity. In 
all scleroderma patients, parenchymal  alterations are detected by HRCT 
in 55–56% of cases, and if they have abnormal  pulmonary function tests, 
the percentage rises up to 91%.  The characteristic findings are ground-
glass attenuation, reticular, and linear pattern, dominantly on lung bases.  
Ground-glass attenuation has been frequently attributed to alveolitis, but 
it  seems that in most cases it presents early phase fibrosis; and only in 
some cases,  it represents the reversible inflammatory disease. It is in 
accordance with biopsy  finding with only less than 25% of scleroderma 
patients having inflammation,  despite ground-glass pattern on HRCT 
scanning 
The honeycombing pattern is not a feature of ILD in scleroderma, 
although in recent study, it was detected in more than 30% of 
symptomatic patients,with a significantly higher incidence in patients 
with limited scleroderma compared to  patients with diffuse scleroderma  
Ultrasound lung comets (ULCs) 60 is an echographic sign of interstitial 
lung fibrosis correlates with HRCT findings. This a simple, bedside, 
radiation-free test. 
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Bronchoalveolar Lavage (BAL) and Lung Biopsy 
The neutrophil with or without eosinophil alveolitis is detected in more 
than 50% of these patients61. It has been shown that high neutrophil count 
in lung lavage fluid is associated with  early mortality,  that active 
alveolitis correlates with more severe lung function, and  it also correlates 
with more extensive fibrosis on HRCT. 
Surgical lung biopsy represents a gold standard in the evaluation of ILD 
as it can show the histopathological type and degree of inflammation and 
degree of fibrosis. It can also show the presence of other causes of 
parenchymal involvement. Lung biopsy specimen analysis has 
demonstrated that the majority of scleroderma-ILD patients show the 
histopathological pattern of NSIP, less often usual interstitial pneumonia 
(UIP) or other types of ILD. Most frequent is fibrotic NSIP, where the 
cellular as well as the UIP variation is quite rare. NSIP is a dominant  
pathologic pattern in 78% of cases. Bronchiolitis obliterans organizing 
pneumonia  (BOOP) is quite rare pathologic finding, as well as diffuse 
alveolar hemorrhage. 
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GASTROINTESTINAL SYSTEM: 
Plain  radiography  images reveals 
 bowel dilatation 
 intestinal obstruction 
 perforation 
 Large-mouthed pseudodiverticula  seen on the antimesenteric 
border, mostly in the transverse and descending colon 
Barium study of the esophagus – Barium swallow 
 Mild to moderate esophageal dilatation 
 Hypotonia and diminished peristalsis in the lower two thirds of the 
esophagus 
 lower esophageal sphincter is patulant 
 Gastroesophageal reflux  
 Erosions and superficial ulcers in the lower esophagus  as a result of 
GERD 
 Fusiform stricture 4-5 cm above the gastroesophageal junction as a 
result of chronic complication of  reflux esophagitis 
 Barrett esophagus  - a fine reticular mucosal pattern is seen distal to the 
stricture 
 Adenocarcinoma – filling defect in barium swallow 
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Barium study of the small bowel – barium meal 
  bowel dilation  
  Increased Transit time  
 megaduodenum or megajejunum 
 pseudodiverticulae/sacculations  -   asymmetrically  distributed squared 
tops with broad bases on the mesenteric side 
 pneumatosis intestinalis  intestinal gas dissects into the bowel wall or 
into the peritoneal cavity, mimicking a perforated bowel. 
Computed tomography - abdomen 
 Indications include 
- Oesophageal cancer  
- Pneumatosis cystoides intestinalis 
- Intestinal obstruction 
In pneumatosis cystoides intestinalis is characterized by intramural gas 
clusters in small and large intestine and pneumoperitoneum. 
Ultrasound Abdomen 
Assessing involvement in liver in primary biliary cirrhosis associated 
with scleroderma. Pancreatic involvement can also assessed.  
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Endoscopy  
In Systemic sclerosis, upper GI scopy or Oesophagogastroduodenoscopy 
is done routinely early in the disease as oesophagitis can occur in 
asymptomatic patients. OGD  shows the presence of dilated lower 
oesophageal sphincter, oesophagitis, candidial oesophagitis, barrett’s 
oesophagus, stricture.  
Biopsy is done in Barrett’s oesophagus when there is suspicion of 
adenocarcinoma.  
On sigmoidoscopy, the mucosa of the colon appears  pale, dry and rather 
rigid, but this is very uncommon. 
Oesophageal Manometry 
Manometry is the gold standard for assessing oesophageal motility 
disorders. 
In most cases, there is low contraction amplitudes in the distal or lower 
oesophagus. In advanced disease there is weak or aperistalsis of the 
smooth muscle part of oesophagus and hypotensive lower oesophageal 
sphincter.  Although this pattern is characteristic of scleroderma it is not 
specific and can occur other conditions including GERD. 
 Upper oesophagus is not involved in scleroderma, if present associated 
myositis must be considered, which may be feature of overlap syndrome. 
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Anorectal pressure measurements show abnormal motility is seen in 74% 
of patients but most  patients are asymptomatic.  
Scintigraphy provide a sensitive quantitative index of esophageal 
dysmotility.  
Celiac and mesenteric angiography 
It  is an accurate  way for  demonstrating the site and the cause of 
gastrointestinal bleeding; it also provides the means for therapeutic 
measures, such as pharmacologic or embolic control of bleeding. 
Investigations for renal involvement  
 elevated serum creatinine levels – usually the rise is acute, rarely it 
can be a gradual increase in the levels. 
 24 hour creatinine clearance is less than 60 ml/ min 
 Urinalysis – after renal crisis, there is proteienuria usually not 
exceeding  2g/ day, microscopic hematuria 10- 100 RBC / HPF, 
granular casts 
 Elevated plasma renin levels 
 Microangiopathic hemolytic anaemia 56– peripheral smear shows 
normochromic fragmented RBCs, schistocytes, reticulocytosis 
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 Thrombocytopenia, rarely it can be as low as 20000/ cu.mm. It is 
often the first indicator of clinical improvement and occurs  before 
fall in serum creatinine levels 
Indicators of muscle involvement 
- Elevated creatine phosphokinase levels 
- excessive creatinuria  
- Electromyography (EMG)  is abnormal in 50% of patients who are 
early in the disease and in 93% in late stages 
- MRI and spectroscopy are useful  non-invasive methods to assess 
the disease activity 
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TREATMENT 
The three basic pathologies of Systemic sclerosis  are potentially 
amenable to therapeutic modulation, and this actually raises the 
possibility of true disease-modifying treatment. Presently vascular 
therapies and immunomodulation are the widely used candidate therapies. 
Antifibrotic treatment remains as a challenge and at present there is no 
proven antifibrotic agent. 
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Disease modifying treatments 
Immunosuppressive agents that are effectively used for controlling 
connective tissue disorders generally have modest or no benefit in  
Systemic sclerosis. 
Corticosteroids  
When  used in  low doses,  it reduces skin sclerosis, arthralgia, myalgia. 
Steroids do not retard the disease  progression, nor does it induce the 
onset of renal crisis.  There are case reports of Systemic sclerosis 
showing improvement with Dexamethasone pulse therapy62. 
Cyclophosphomide 63 has shown to retard the progressive of early ILD. 
Improvement in pulmonary function tests and HRCT is seen. It also 
produces a modest improvement in skin induration. Cyclophosphomide 
can be given daily orally or as intermittent intravenously. It is generally 
given at the dose 1-2 mg/kg/day for 6 – 12 months, although optimal 
duration of therapy is yet to be determined. Potential toxicities associated 
with the drug include bone marrow suppression, hemorrhagic cystitis, 
bladder carcinoma, premature ovarian failure, opportunistic infections. 
Methotrexate shows moderate improvement in skin induration, its 
profibrotic effect leading to liver cirrhosis and ILD raises concern about 
using this drug. 
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Mycophenolate mofetil, azathioprine, cyclosporine, thalidomide, 
rapamycin, extracorporeal photophoresis have been reported to useful. 
Autologous stem cell transplantation is still in experimental stage. 
 
Antifibrotic agents 
D – penicillamine is antifibrotic, immunosuppressive agent, it prevents 
crosslinking of extracellular collagen fibers. It improves skin induration, 
prevents  organ involvement and increases survival. Studies have shown 
that there is no difference in treatment outcome between standard dose 
750 mg/day and very low dose 125mg alternate day 67. 
Minocycline, INF γ , relaxin has failed to show improvement. 
 
Treatment of Raynaud’s phenomenon 
Lifestyle modifications 
 Protecting from environmental cold, especially in winters 
 Using gloves and socks. Electrically heated gloves are now available. 
 Avoiding use of cold water for washing 
 Warming of hands in hot water for 5 – 10 minutes 65 
 Avoid smoking 
 Avoid Beta blockers 
 Avoiding use of vibratory tools 
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Pharmacological agents 
Vasodilators –  
1. Calcium channel blockers (CCB) -  most commonly used  and 
efficacious drugs.  Nifedipine 64 10 – 20 mg four times a day. 
calcium channel blockers  relaxs  the lower oesophageal sphincter 
and can  exacerbate gastroesophageal reflux disease 66. 
2.  Angiotensin II receptor blockers (ARB) -   effective and can be 
used alone or in  combination with CCB.  
3. α 1 adrenergic receptor blocker - Prazosin – 1mg three times a day 
4. Ketanserin – 20 – 40 mg three times a day 
5. Intravenous alprostadil (prostaglandin E1) is used  in  refractory 
Raynaud's phenomenon 
6. Oral iloprost  
7. oral sildenafil has shown improvement in a study 
Care should be taken so that the vasodilators do not excessively lower 
systemic blood pressure and diminish blood flow to the fingers. 
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Others 
 Low dose aspirin prevent platelet aggregation  and is used as an 
adjuvant. 
Pentoxifylline 
Nerve block 
Sympathectomy 
Biofeedback 
Treatment of skin sclerosis 
As skin sclerosis is not life threatening and may regress spontaneously 
over a period of time, aggressive treatment for sclerosis is not advocated. 
1. Low dose steroids – 5mg of Prednisolone is given for short 
courses. Steroids neither stops the progress of the disease nor 
induces renal crisis 
2. D- penicillamine 67  - retrospective studies have shown 
considerable improvement in skin induration  
3. Cyclophosphomide – modest improvement 
4. Methotrexate – modest improvement 
Moisturizing the skin and regular massaging of skin can be helpful. 
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Calcinosis cutis 
Surgical removal 
Carbondioxide Laser has superceded surgery 
Low dose warfarin reduces inflammation around the calcium deposits 
Nifedipine has been reported to be helpful 
Telengiectasia 
 Can be removed for cosmetic purpose using Pulsed dye Laser 
Treatment of Gastrointestinal complications 
1. Antireflux measures 
Lifestyle modifications 
 Elevation of  head end of the bed using  pillows and  blocks 
 Heavy  meals at noon, lighter meals at night. 
 Taking frequent small meals.  
 Avoiding food or liquids two hours before sleep. 
 Quit  smoking. 
 Avoid spicy foods that increase acid production 
 Nifedipine  can relax  lower esophageal  sphincter resulting in 
reflux of food 66.  
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Specific treatment for Reflux 
1. Drugs decreasing acid secretion – H 2 blockers, Proton Pump 
Inhibitors 
2. Prokinetic drugs –These may be required in higher doses for 
treating reflux in scleroderma3. 
 
     2 . watermelon stomach – recurrent bleeding can occur and can be    
            treated    by     Laser photocoagulation 
3. Malabsorption and malnutrition – rotational therapy using broad 
spectrum antibiotics like tetracycline, metronidazole, erythromycin 
to eradicate bacterial overgrowth. If malnutrition is severe, 
parentral hyperalimentation is indicated. 
4. Octreotide injections are found helpful in chronic hypomotility 
present in Systemic sclerosis. 
 
Treatment of respiratory complications 
PAH 
Continuous intravenous infusion of epoprostenol (prostacyclin) was the 
first line of management  for pulmonary arterial hypertension in SSc 
patients. It is difficult to use as it is given in intensive care setup. 
Nowadays  they used only  in severe cases. 
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Most cases are treated with oral agents like  
 Endothelin -1 receptor antagonists – bosentan, sitaxsentan 68 
 phosphodiesterase 5 inhibitor – sildenafil 
 
If hypoxemia is present, oxygen supplementation should be given to 
prevent hypoxemia induce pulmonary vasoconstriction. 
Inhaled delivery systems for iloprost have been introduced recently. 
Lung transplantation is the last measure in patients who fail the above 
lines of management.  
 
ILD 
Cyclophosphomide has shown to retard the progress of early ILD. 
Improvement in pulmonary function tests and HRCT is seen. 
Cyclophosphomide can be given daily orally or as intermittent 
intravenously63.  
It is generally given at the dose 1-2 mg/kg/day for 6 – 12 months, 
although optimal duration of therapy is yet to be determined. Other drugs 
used are carbocysteine and low dose corticosteroid. 
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Renal crisis 
Scleroderma renal crisis is a medical emergency, the outcome is mainly 
determined by the extent of renal damage at the time of initiation of 
treatment.  Prompt recognition of early or impending scleroderma renal 
crisis is essential to avoid renal damage. Regular monitoring of blood 
pressure is advised.  If the systolic blood pressure increases by 20 mmHg  
or the diastolic blood pressure increases by 10 mmHg from the baseline 
values,  renal crisis should be suspected. Treatment is with ACE 
inhibitors is crucial. With the use of ACE inhibitors in SRC, the mortality 
have come down 45. Non Steroidal Anti Inflammatory Drugs (NSAID) 
and glucocorticoids should be avoided. Short term dialysis is done and 
after recovery dialysis is discontinued. If the patient is unable to 
discontinue dialysis even after 1 – 2 years renal transplantation should be 
considered. 
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AIM OF THE STUDY
1. To study the epidemiological features of Systemic sclerosis with respect 
to incidence, age of onset, sex.
2. To study the occupational risk factors for Systemic sclerosis.
3. To study the skin manifestations of Systemic sclerosis.
4. To study the systemic manifestations of  Systemic sclerosis.
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MATERIALS AND METHODS 
This study was conducted in the Department of Dermatology, Government Rajaji 
Hospital, Madurai during the period of  september 2012 to August 2014 (24 
months) 
INCLUSION CRITERIA:  
All consenting patients  fulfilling ARA criteria for systemic sclerosis  
 major criterion - Scleroderma proximal to digits, affecting limbs, face, 
neck or trunk 
                           or  
 two minor criteria - 
                (a) sclerodactyly 
                (b) digital pitted scarring 
           (c) bilateral basal pulmonary fibrosis 
 
EXCLUSION CRITERIA:  
1) Patients not consenting for examination 
2) Patients not fulfilling ARA criteria for systemic sclerosis 
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All the patients attending the outpatient department of  Dermatology,  
Government Rajaji Hospital were screened during the study period between 
September 2012 and August 2014 and patients satisfying the above mentioned 
criteria were enrolled in the study. After getting their informed consent, a detailed 
history was taken and a thorough dermatological and systemic examination was 
done. 
The parameters studied were the age of onset, duration of disease, sex ratio, 
occupation, duration of exposure to harmful environmental factors, presenting 
complaint, extent of skin involvement, presence of sclerodactyly,                
fingertip ulcer, stellate scars, gangrene, digit loss, scleroderma facies,       
Raynaud’s phenomenon, neck sign, round finger pad sign, calcinosis cutis, 
pigmentary changes, nail involvement, loss of hair in the extremities, hypohidrosis, 
leg ulcer,  associated skin diseases. Systemic involvement was evaluated clinically 
and investigations including complete blood count, ESR, renal function tests,            
blood sugar, liver function tests,  urine routine were done for all the cases.           
X-ray chest PA view, HRCT – chest, Pulmonary function test,                   
ultrasound of abdomen and pelvis, ECG, ECHO, Barium Swallow, upper GI 
scopy, X ray of both hands were done for all the cases. In selected cases EMG, 
muscle biopsy, skin biopsy, DIF, ANA, Scl 70, U1RNP, and dsDNA was done.  
All the data was further compiled and inferences were drawn. 
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OBSERVATIONS AND RESULTS 
In this study, 20 cases of  Systemic sclerosis were enrolled in the 
Department of Dermatology, Government Rajaji Hospital, Madurai, during 
a study period of two years. The following observations were noted. 
 
INCIDENCE 
The total number of patients who attended the Dermatology out patient 
department during the study period was 100814. The number of patients 
diagnosed with Systemic sclerosis were 20, so the overall incidence of 
Systemic sclerosis was found to be 0.2 per dermatology cases. 
 
TABLE 1 – INCIDENCE OF SYSTEMIC SCLEROSIS 
Total no of patients 
attending Dermatology OP 
 
100814 
Patients diagnosed with 
Systemic sclerosis 
 
20 
Incidence per 1000 cases                    0.2 
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SEX RATIO 
In our study, out of 20 cases,   3 cases (15 %) were males and  17 (85%) 
cases were females. The female: male ratio was 5.67 : 1  (Table 2, figure 1) 
TABLE 2- SEX RATIO 
 
GENDER NO. OF CASES 
Male 3 
Female 17 
 
FIGURE 1 – SEX RATIO 
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AGE OF ONSET 
In our study the minimum age of onset of the disease was 10 years whereas 
the maximum age reported was  53  years.  Most of the patients were 
between the ages of  21 - 50 years when the disease started . Mean age of 
onset was 36 yrs. ( Table 3, figure 2) 
TABLE 3 -  AGE OF ONSET 
 
Age interval Male Female Total percentage 
0-20 0 1 1 5% 
21-30 1 5 6 30% 
31-40 0 5 5 25% 
41-50 2 4 6 30% 
51-60 0 2 2 10% 
 
FIGURE 2 - AGE OF ONSET 
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OCCUPATION – EXPOSURE TO ENVIRONMENTAL FACTORS 
Exposure to environmental factors which can contribute to the 
pathogenesis was present in 11 patients.  Pesticides, solvents, firework 
were commonly involved. Exposure to silica was seen in one patient. 
(Table 4, figure 3) 
TABLE   4 -   EXPOSURE TO ENVIRONMENTAL FACTORS 
Exposure Males Females Total no. of 
patients 
Percentage 
Nil 1 8 9 45% 
Silica 1 0 1 5% 
Solvent 1 2 3 15% 
Pesticides 0 4 4 20% 
Firework 0 3 3 15% 
 
FIGURE 3 – EXPOSURE TO ENVIRONMENTAL FACTORS 
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PRESENTING COMPLAINT  
The most common presenting complaint was tightness of skin which was 
in about 35 % of cases. ( Table 5, figure 4) 
TABLE 5 - PRESENTING COMPLAINT 
Presenting complaint No. of patients Percentage 
Skin tightness 7 35% 
Pigmentary change 4 20% 
Fingertip ulcers 3 15% 
Raynaud’s phenomenon 2 10% 
GERD 1 5% 
Dyspnoea 1 5% 
Diarrhea 1 5% 
Arthralgia 1 5% 
 
FIGURE 4 – PRESENTING COMPLAINT 
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DURATION OF ILLNESS 
Most patients presented within 2 years of onset of disease. Only 3 patients 
waited for more than 6 years to seek medical help. Mean duration of illness 
is 3.3 years.(Table 6, figure 5) 
 
 TABLE 6-  DURATION OF ILLNESS 
 
  
 
FIGURE 5 – DURATION OF ILLNESS 
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Duration No. of patients Percentage 
0-1 year 5 25% 
1-2 years 3 15% 
2-3 years 4 20% 
3-4 years 2 10% 
4-5 years 3 15% 
5-6 years 0 0% 
6-7 years 2 10% 
7-8 years 1  5% 
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 SKIN INVOLVEMENT 
Skin tightness was present in all 20 patients, Raynaud’s phenomenon was 
noted in 13 patients, fingertip ulcers in 12 patients. Two patients had 
gangrene.  One patient had malar rash and one had blisters in leg (Table 7, 
figure 6) 
TABLE 7  -    SKIN INVOLVEMENT 
History No. of patients Percentage 
Skin tightness 20 100% 
Raynaud’s 
phenomenon 
13 65% 
Fingertip ulcers 12 60% 
Gangrene 2 10% 
Malar rash 1 5% 
Blister 1 5% 
 
FIGURE 6 – SKIN INVOLVEMENT 
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 SYSTEMIC INVOLVEMENT 
Most common systemic complaint was retrosternal burning, next common 
being dyspnoea. All complaints relating to systemic involvement are 
enumerated in    Table 8, figure 7 
TABLE 8 -  SYSTEMIC INVOLVEMENT 
 
History No. of patients Percentage 
Cough – dry type 7 35% 
Dyspnoea 15 75% 
Chest pain 1 5% 
Myalgia 9 45% 
Arthralgia 9 45% 
Proximal muscle 
weakness 
4 20% 
Dysphagia 8 40% 
Retrosternal burning/ 
regurgitation 
17 85% 
Altered bowel habits 3 15% 
GI bleeding 0 0% 
 
FIGURE 7- SYSTEMIC INVOVEMENT 
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EXTENT OF SKIN SCLEROSIS 
Skin tightness of  hand, forearm, arm and face was seen in all patients.   
Lower limb was less frequently involved (Table 9, figure 8) 
                         TABLE 9 -  EXTENT OF SKIN SCLEROSIS 
 
Site No. of patients Percentage 
Hand 20 100% 
Forearm 20 95% 
Arm 20 85% 
Face 20 100% 
Chest 8 40% 
Abdomen 4 20% 
Feet 2 10% 
Leg 5 25% 
Thigh 2 10% 
 
FIGURE 8 – EXTENT OF SKIN SCLEROSIS 
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MODIFIED RODNAN SCORE 
Modified Rodnan Skin Score was measured at 17 sites.  Minimum score 
was 13 and maximum was 37. Mean score was 18. 
SKIN CHANGES IN FACE  
Difficulty in retracting the lower eyelid was seen in all patients. Difficulty 
in opening the mouth was present in 18 cases. Pinched nose and fish mouth 
appearance were seen 14 patients. One had telengiectasia in the cheeks. 
(Table 10, figure 9) TABLE 10  -   SKIN CHANGES IN FACE 
Skin change No of patients Percentage 
Pinched nose 14 70% 
Radial furrow/ fish 
mouth 
14 70% 
Difficulty in mouth 
opening  
18 90% 
Difficulty in 
retraction of lower 
eyelid 
20 100% 
Malar rash 1 5% 
Telengiectasia  1 5% 
 
FIGURE 9 – SKIN CHANGES IN FACE 
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SKIN CHANGES IN HAND 
All 20 patients had sclerodactyly. Stellate scars were present in 18 patients 
and round finger pad sign in 17 patients. Two patients had loss of digits.                
(Table 11, figure 10) 
                        TABLE 11  -  SKIN CHANGES IN HAND 
Skin changes No. of patients Percentage 
Sclerodactyly 20 100% 
Stellate scars 18 90% 
Digit loss 2 10% 
Round finger pad sign 17 85% 
 
FIGURE 10 – SKIN CHANGES IN HAND 
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CHANGES IN PIGMENTATION 
Generalised hyperpigmentation was seen in 9 patients. Salt and pepper 
pigmentation was present in 19 patients.( Table 12, figure 11) 
                TABLE 12  -  CHANGES IN PIGMENTATION 
 
Skin change No. of patients Percentage 
Generalized 
hyperpigmentation 
9 45% 
Salt and pepper 
pigmentation 
19 95% 
 
 
 
FIGURE 11 – CHANGES IN PIGMENTATION 
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OTHER SKIN CHANGES  
Calcinosis cutis was present in two patients. Neck sign was seen in 16 
patients. Loss of hair in the extremities was seen  in 10 patients  and 
hypohidrosis in 13 patients. One patient had leg ulcer.  
              TABLE  13   -  OTHER SKIN CHANGES 
Skin change No. of patients Percentage 
Calcinosis cutis 2 10% 
Neck sign 16 80% 
Leg ulcer 1 5% 
Loss of hair – 
extremities 
10 50% 
Hypohidrosis 13 65% 
 
NAIL INVOLVEMENT  
Most common nail change was ragged cuticle and was seen in 11 patients. 
Two had racquet nails and one had longitudinal melanonychia (Table 14) 
                   TABLE 14  NAIL INVOLVEMENT 
Nail change No. of patients Percentage 
Ragged cuticle  11 55% 
Racquet nail 2 10% 
Longitudinal 
melanonychia 
1 5% 
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Evaluation of blistering disorder  
One patient had multiple, tense  vesicles of both upper and lower limb. 
 It was associated with intense itching. 
Oral erosions were present 
 Nikolsky – negative  
Bulla spreading sign – positive 
 Tzanck smear showed eosinophils and   acantholytic cells were absent. 
Biopsy showed normal epidermis, increased collagenisation of the dermis, 
subepidermal bulla.  
DIF  showed linear and granular deposits of IgG, IgM, IgA, fibrin, C3 
along basal layer. 
Salt split technique showed IgA and C3 along the dermal side of the split. 
 ANA  - positive 
Scl 70 - positive 
dsDNA -  negative 
patient did not fulfill the ARA criteria for SLE 
All these features were suggestive of  Epidermolysis bullosa Acquisita 
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EXAMINATION OF RESPIRATORY SYSTEM 
On auscultation, crepitations were present in basal lung fields in 8 patients. 
Chest expansion was decreased in 18 patients ( Table 15) 
          TABLE 15 - EXAMINATION OF RESPIRATORY SYSTEM 
 
Findings No. of patients Percentage 
Auscultation - 
crepitations 
8 40% 
Decreased chest 
expansion 
18 90% 
 
 
MUSCLE INVOLVEMENT 
Proximal muscle weakness was present in four patients but tenderness  was 
seen in one patient. In this patient EMG showed low amplitude, slow 
wave, polyphasic fibrillation.  Muscle biopsy was done and it showed 
cross and longitudinal section of muscle bundle with intervening fibrosis 
and fatty tissue. Focal area show degenerating and regenerating muscle 
fibres with inflammatory cell infiltrate, suggestive of myositis. 
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ASSOCIATED CONDITIONS 
Common dermatological diseases like psoriasis, dermatophytosis, tinea 
versicolor, plantar wart were seen in  few Systemic sclerosis patients. Two 
patients had hypothyroidism ( Table 16) 
                 TABLE   16  -   ASSOCIATED CONDITIONS 
Condition No of patients Percentage 
Psoriasis 1 5% 
Dermatophytosis 2 10% 
Tinea versicolor 1 5% 
Plantar wart 1 5% 
Hypothyroidism 2 10% 
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COMPLETE BLOOD COUNT  
Anaemia was present in 5 patients. ESR was elevated in   (Table  17) 
 
TABLE  17   -   COMPLETE BLOOD COUNT 
 
CBC No. of patients Percentage 
Anaemia 5 25% 
Elevated ESR 14 70% 
 
 
RFT/LFT 
All 20 patients had normal renal and liver function test 
 
 
Urine Routine  
Urine routine was within normal limits in all 20 patients. No patient had 
proteinuria 
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IMAGING STUDIES FOR LUNG INVOLVEMENT 
For detecting lung involvement both Chest X ray PA view and HRCT – 
chest were done. Features of  Interstitial Lung Disease was seen in 12 
patients’s chest Xray and 19 patients’s HRCT. (Table  18) 
TABLE 18  -  IMAGING STUDIES FOR LUNG INVOLVEMENT 
Test  No. of patients 
 
 having ILD 
Percentage 
Chest Xray PA view 12 60% 
HRCT – chest 19 95% 
 
PULMONARY FUNCTION TEST 
Pulmonary function test showed normal spirometry in one patient. In rest              
19 patients restrictive type was noted  of which 4 had mild restriction and 
15 had moderate restriction.( Table  19) 
                  TABLE  19  -  PULMONARY FUNCTION TEST 
Pattern No.of patients Percentage 
Normal 1 5% 
Mild restriction 4 20% 
Moderate restriction 15 75% 
Severe restriction 0 0% 
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ECG 
Electrocardiography was within normal limits in 19 patients. One patient 
had low voltage  QRS complex (Table 20) 
                                   TABLE 20  -  ECG CHANGES 
ECG changes No. of patients Percentage 
Within normal limits 19 95% 
Low voltage QRS 
complex 
1 5% 
 
ECHO CARDIOGRAM 
In this study, ECHO Cardiogram was found to be normal in 19 patients. 
Pulmonary Arterial Hypertension was present in one patient. (Table 21) 
                         TABLE 21 – ECHO CARDIOGRAM 
 
ECHO No. of patients Percentage 
Normal 19 95% 
Pulmonary Arterial 
Hypertension 
1 5% 
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BARIUM SWALLOW 
Barium swallow done showed normal motility in 18 patients, dysmotility 
in 1 patient and narrowing of  thoracic oesophagus in 1 patient. (Table 22) 
                             TABLE 22 -  BARIUM SWALLOW 
Finding No. of patients Percentage 
Normal  18 90% 
Dysmotility 1 5% 
Narrowing of 
thoracic oesophagus 
1 5% 
 
UPPER GI SCOPY 
Upper GI scopy was done for all 20 patients, it was normal in 11 patients. 
Oesophagitis was present in 8 patients and lax gastroesophageal sphincter 
was present in one patient.( Table 23) 
                        TABLE 23  -   UPPER GI SCOPY 
Finding No. of patients Percentage 
Normal 11 55% 
Oesophagitis 8 40% 
Lax sphincter 1 5% 
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X RAY OF HANDS 
Xray of hands showed acral osteolysis in 15 patients and osteopenia in 5 
patients. It was normal in 4 patients. (Table 24, figure 12) 
                          TABLE 24  -  X RAY OF HANDS 
 
Finding No. of patients Percentage 
Normal 4 20% 
Acral osteolysis 15 75% 
osteopenia 5 25% 
 
FIGURE 12 – X RAY OF HANDS 
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ULTRASOUND ABDOMEN 
Ultrasonography of abdomen and pelvis was normal in 17 patients. Two 
patients had renal calculi and one had increased renal cortical echoes.          
( Table 25) 
              TABLE  25  -  ULTRASOUND ABDOMEN 
Finding  No. of patients Percentage 
Nil 17 85% 
Renal calculi 2 10% 
Increased renal 
cortical echoes 
1 5% 
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DISCUSSION 
We enrolled 20 cases of  Systemic sclerosis in this study which was done 
over a span of two years. 
INCIDENCE 
Out of a total of 100814 cases visiting the dermatology out-patient 
department during the study period the cases with Systemic sclerosis were 
20. Thus the incidence rate of Systemic sclerosis was 0.2 per dermatology 
cases. 
Incidence of the disease show a wide variation in the studies conducted so 
far. The incidence of Systemic sclerosis in US is 20 per million population. 
In a study conducted by Giersson et al75 in Iceland, the incidence was 3.8 per 
million population. Roberts- Thomson et al76 found the incidence to be 15 
per million in their study in Australia. Epidemiological data from India is 
lacking. 
SEX RATIO 
In our study the male to female ratio was 1: 5.7,  showing a female 
preponderance. This is similar to the previous studies.  In a study done in 
North India by Sharma VK et al74 the ratio was 1 : 5.2.  
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Roberts- Thomson et al76 found the ratio to be 1:5 in Australia.  In Afro 
Caribbean population, Flower et al73 observed the ratio to be 1:4.6 
AGE OF ONSET 
The youngest patient reported to have Systemic sclerosis in our study was of 
age 10 years and the maximum age reported was 53 years. 
Patients were most commonly  in the third, fourth and fifth decade. 95% of 
patients were in the age group 21- 60 years.  Similarly Ghosh et al81, in 
Eastern India found that  85 % of patients were in the age group                
21- 60 years.  
In our study, the mean age of onset was 36 years. This is comparable with 
the previous studies from India. In the north Indian study conducted by 
SharmaVK et al74 the mean age of onset was 32.75 years. In Eastern India, 
Ghosh et al81 found the mean age of onset to be 29.6 years.  
OCCUPATION – EXPOSURE TO ENVIRONMENTAL FACTORS 
Environmental factors can contribute to the pathogenesis.  Exposure to such 
substances were  present in 11 patients (55%).  Solvents (15%), 
pesticides(20%) , firework (15%) were commonly involved. Exposure to 
silica was seen in one patient. 
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Diot, Lesire, Guilmot, et al77 in their case control study had shown 
significant association with occupational risk factors like silica, solvents, 
epoxy resins.  
PRESENTING COMPLAINT 
In our study, the most common presenting complaint was skin tightness, 
seen in about 35%. Eventhough tightness was present in all 20 cases at the 
time of presentation it was the concern of the patient only in 35%. Similarly  
pigmentary change was present in 95%, but it was the presenting complaint 
in only 20%. Other presenting complaints include fingertip ulcers, 
Raynaud’s phenomenon, GERD, dyspnoea, diarrhea, arthralgia.  
DURATION OF ILLNESS 
In our study Duration of illness varied between 4 months to 8 yrs and the 
mean duration of illness was 3.3  years.  
In the study done by Sharma VK et al74, the mean duration was 6.75 years.     
Reveille JD et al71 reported the duration as 2.5 years in Hispanics, 2 years in 
African Americans and 1.7 years in Americans presenting to Rheumatology 
clinic.    Ghosh et al81 in his study done in Eastern India reported the 
duration as 23 months. 
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SKIN INVOLVEMENT 
Most common involvement of skin was tightness of skin which was present 
in all cases (100%).  Next common were Raynaud’s phenomenon                  
( 13 cases – 65%) and fingertip ulcers (12 cases – 60%).  
Raynaud’s phenomenon was found in more number of patients in studies 
done by Sharma et al74 in North India (92.9%) , Ruangjutipopan et al70 in 
Thailand ( 94.1%) and Al Adhadh et al72 in Saudi Arabia ( 100%). Low 
percentage in our study is probably because of higher temperature 
throughout the year in South India.  
Fingertip ulcers were present in 58.6%, 53.6% and 47.4% in the studies   
done by Sharma et al74,  Ruangjutipopan et al70,    Krishnamurthy et al69 
respectively. This is comparable to the observation made in our study. 
Gangrene was present in two cases (10%), this is similar to the study done 
by Sharma et al74 (6.7%). 
SYSTEMIC INVOLVEMENT 
In our study, Retrosternal burning sensation and regurgitation was present in 
17 patients (85%). This was similar to the studies done in US by             
Flower et al73 and  Reveille JD et al71.   
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 Dysphagia was present in 8 patients (40%) and altered bowel habits was 
present in 3 cases (15%).  Of the three patients two had diarrhea and one had 
constipation.  Similarly, dysphagia was present in 35.2 % in the study done 
by Sharma et al74 and  in  41.2 % in the study done by Ruangjutipopan et al70 
in Thailand. Whereas in Al Adhadh et al72 recorded a higher incidence of 
87% in Saudi Arabia. 
In our study, 15 patients (75%) had breathlessness and 7 (35%) out of them 
had dry cough. This was higher than the  previous studies done by       
Sharma et al 74(51.1%), Al Adhadh et al72( 57.4%),                   
Krishnamurthy et al69(19.2%). 
 One patient (5%) had chest pain, when evaluated was found to have 
pulmonary arterial hypertension. 
Myalgia and arthralgia were present in 9 cases (45%). This was similar to 
the studies done by Sharma et al74 ( 36.7%) and Ruangjutipopan                   
et al70 ( 52.3%), whereas it was higher in studies done by Krishnamurthy et 
al69 (66.7%) and  Al Adhadh et al72(96 %).  
 
 
95 
 
 Proximal muscle weakness was present in 4 cases. Of which one patient had 
severe muscle tenderness, elevated muscle enzymes, EMG and muscle 
biopsy suggestive of myositis. She also had malar rash. ANA was positive. 
U1RNP was positive. This patient was a case of overlap syndrome – 
Systemic sclerosis, SLE and Dermatomyositis – Mixed connective tissue 
disease. 
EXTENT OF SKIN SCLEROSIS 
In our study, most common sites involved were hand, forearm, arm and face, 
which was present in all 20 cases (100%). Involvement of chest in 40 % , 
abdomen in 20 %. Lower limb was the  least common site.  Involvement in  
legs 25%, thigh and feet in 10 %. This is similar to previous studies done, 
Sharma VK et al74 reported  skin sclerosis in 98.5%, Krishnamurthy V et al69 
in 100%, Al Adhadh et al72 in 96.5%. 
In our study, Modified Rodnan skin score varied between 13 and 37, mean 
score being 18. This is similar to the study done by Reveille JD et al71 in US 
where the score was 14 in whites , 15 in Hispanics and 16 in  African 
Americans. But it is low compared to a study done in North India done by 
Sharma et al74 where the score was 25.81. The variation in the score is due to 
the difference in the stage in which the patients were examined. 
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SKIN CHANGES IN FACE 
In our study, 14 patients (70%) had pinched nose and fish mouth appearance 
and 18 patients (90%) had difficulty in opening the mouth.  
In all 20 patients difficulty in retracting the lower eyelid was present. One 
patient had malar rash and one had telengiectsia. 
Similar to our study, difficulty in mouth opening was present in 82.6%,  in 
the study by Ghosh et al81.  But in the study by Sharma et al74 difficulty in 
mouth opening was present only in 55.5%. 
 Telengiectasia was present only in one patient (5%)  in our study. But 
higher incidence of telengietasia have been reported by Flower et al73  in 
Afro Caribbean as 48%, Sharma et al74 in North India as 36.8% and Ghosh 
et al81 in East India as 23.1%.  
SKIN CHANGES IN HAND 
In our study, sclerodactyly was present in all 20 patients (100%), similar to 
the study done by Ghosh et al81 in East India where it was present in 82.6%.  
Stellate scars in digits were present noted in 18 (90%) patients, which was a 
little higher compared to the previous studies done by Ghosh et al81 (63%) 
and Flower et al73 (70%).  
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 Round finger pad sign was present in 17 (85%) patients whereas Mizutani et 
al31 described in 100 % patients.  In all 13 patients who had Raynaud’s 
phenomenon, Round finger pad sign was present.  
Round finger pad sign was present in 4 cases who did not have Raynaud’s 
phenomenon. These 4 patients had fingertip scars. This is could be due to 
vascular involvement,  in the absence or subclinical  Raynaud’s phenomenon 
leading to loss of pulp tissue. 
Two patients (10%) had loss of digits due to gangrene. This is similar to 
studies done by Sharma et al74 (6.7%) and        Ghosh et al81 (6.5%) 
CHANGE IN PIGMENTATION 
Salt and pepper pigmentation was present in 19 (95%) patients. This is 
relatively high when compared to studies done by Sharma et al74 (51.2%) 
and     Ghosh et al81 (54.3%).  
Generalized hyperpigmentation was noted in 9 (45%) patients. Similar 
occurrence was noted in the study done by Ghosh et al81 (36.9%). Whereas 
Sharma et al74 recorded  88.1% patients with diffuse hyperpigmentation. 
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OTHER SKIN CHANGES 
In our study, neck sign was positive in 16 (80%) patients. This is similar to 
the report by Barnett A.J. 32who initially recorded neck sign in 90%. Ghosh 
et al81 recorded calcinosis cutis in 2.2 % and Flower et al73 in 11%, similarly 
in our study  calcinosis cutis was present in 5%.  
 Loss of hair in extremities was noted in 10 (50%) patients.  Hypohidrosis 
was seen in 13 (65%) patients. One patient had leg ulcer. 
One patient had multiple, tense vesicles of both upper and lower limb. It was 
associated with itching. Nikolsky – negative, bulla spreading sign – positive. 
She also had oral erosions. With clinical findings, a differential diagnosis of  
lymphangiectatic blister due to sclerosis, associated autoimmune blistering 
disorders like bullous SLE, Epidermolysis bullosa Acquisita were 
considered. 
Tzanck smear showed eosinophils and acantholytic cells were absent. 
Biopsy showed normal epidermis, increased collagenisation of the dermis, 
subepidermal bulla. DIF was done, it showed linear and granular deposits of 
IgG, IgM, IgA, fibrin, C3 along basal layer. Salt split technique showed IgA 
and C3 along the dermal side.   
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ANA  and Scl 70 were positive but dsDNA was negative. There was no 
other clinical feature of SLE, ARA criteria was not fulfilled. With these 
findings a diagnosis of Epidermolysis bullosa Acquisita was made. 
NAIL INVOLVEMENT 
Ragged cuticle was seen in 11 (55%) patients. Other nail changes present 
were racquet nail (10%)  and longitudinal melanonychia(5%). Elmansour et 
al78 recorded ragged cuticle in 37.5% patients and longitudinal melanonychia 
in 12.5%. 
ASSOCIATED CONDITIONS 
Few other skin conditions were observed in Systemic sclerosis patients.  A 
single case each of psoriasis, tinea versicolor, plantar wart and two cases of 
dermatophytosis were noted. Two patients had hypothyroidism. One patient 
had overlap with connective tissue diseases SLE and dermatomyositis. 
COMPLETE BLOOD COUNT 
Anaemia was recorded in 5 (25%) patients and elevated ESR was recorded 
in 14 (70%) patients in our study. In our study, ESR values did not correlate 
with the severity of the disease.  Elevated ESR was also seen in the studies 
by Sharma et al74 (87.8%) and  Krishnamurthy et al69 (70.5%). 
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RFT &  LFT 
All 20 patients had normal liver and renal function test. 
Urine routine was normal in all patients, no patient had proteinuria. 
No patient in  the study had renal involvement. This was the same  in the 
study by Krishnamurthy et al69 done in South India. Similarly Sharma et al74 
recorded proteinuria in 6% patients in north India. This is strikingly low 
when compared to western literature where Cannon et al79 recorded 
proteinuria in 36%, abnormal RFT  in  19% patients. Palma A et al80 also 
recorded abnormal parameters in 45% patients. 
RESPIRATORY SYSTEM 
On examination, 18 (90%) patients had decreased chest expansion and crepts 
were heard in the basal lung fields in 8 (40%) patients. 
In our study, Interstitial lung disease was present in 19 (95%) patients. 
Diagnosis was made by HRCT chest. Of these 19 patients, only in 12 
patients Chest X ray showed lung involvement. This is higher compared to 
studies done by Sharma et al74 (65%), Flower et al73 (30%), Krishnamurthy 
et al69 (21.8%)  
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Pulmonary function test showed mild restrictive pattern in 4 (20%) patients 
and moderate restrictive pattern in 15 (75%) patients.  
CARDIOVASCULAR SYSTEM 
ECG was within normal limits in 19 patients. One patient had low voltage 
QRS complex, on subsequent ECHO cardiogram, no abnormality was found. 
ECHO showed pulmonary arterial hypertension in one (5%) patient. This is 
similar to studies done by Flower et al73 and Reveille JD et al71. 
GASTROINTESTINAL SYSTEM 
Upper GI scopy showed oesophagitis in 8 (40%) patients and lax 
gastroesophageal sphincter in one (5%) patient.  
Barium swallow study showed dymotility in one (5%) patient and narrowing 
of thoracic oesophagus in  one (5%) patient. Study done in South India by 
Krishnamurthy et al69 showed 20.4%, similar to our study.  A higher 
incidence of abnormalities have been recorded in studies done by Sharma et 
al74 (70.2%), Reveille JD et al71 (70%) 
 
 
102 
 
X RAY OF HANDS 
In our study, X ray of hands showed acral osteolysis in 15 (75%) patients 
and osteopenia in 5 (25%) patients. Results were comparable  to the study 
done by Sharma VK et al74 where acral osteolysis was present in 58.3% and 
osteopenia in 19.4%. 
Out of the 13 patients who had Raynaud’s phenomenon, 11(84.6%) had 
acral osteolysis. Out of the 18 patients with fingertip scars, 15 (83.3%) had 
acral osteolysis. Hence acral osteolysis correlates with Raynaud’s 
phenomenon and fingertip scars. 
ULTRASOUND ABDOMEN 
Ultrasound abdomen was normal in 17 patients. In two patients renal calculi 
was present. One patient had increased renal cortical echoes, but she had 
normal renal function test and no proteinuria. 
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SUMMARY 
1. Total number of cases enrolled were 20. 
2. Incidence of Systemic sclerosis was 0.2 per 1000 dermatology cases. 
3. The female to male ratio was 5.7:1. 
4. 95% of cases were in the age group 21 -60 years 
5. Youngest case was 10 years old and oldest was 53 years. 
6. Occupational exposure to silica, solvents, pesticides and firework 
were present in 11 cases. 
7. Mean duration of illness was 3.3 years. 
8.  Tightness of skin was seen in 100 % cases. 
9. Skin tightness was the presenting complaint in 35% patients. 
10. Hands, forearm, arm,  face were involved in all cases. Lower limbs 
were less frequently involved. 
11. Mean Modified Rodnan score was 18.  
12. Difficulty in retracting the lower eyelid was present in all cases. 
13. Pinched nose was seen in 70% 
14. Fish mouth appearance and radial furrows around mouth was seen in 
70% cases. 
15. Difficulty in opening the mouth was present in 90 % cases. 
16. All patients had sclerodactyly. 
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17. Raynaud’s phenomenon was present in 65 %. 
18. Fingertip ulcers were present in 60 % cases. 
19. Stellate scars in the digits were present in 90%. 
20. Round finger pad sign was seen in 85% cases. 
21. All patients with Raynaud’s phenomenon had Round finger pad sign. 
22. 42% of patients without Raynaud’s phenomenon had                 
Round finger pad sign. 
23. Two patients had gangrene and amputation of digits were done. 
24. Pigmentary change was the second most common complaint  
25. Salt and pepper pigmentation was present in 95% cases, most 
common site being retroauricular. 
26. Generalized hyperpigmentation was seen in 45% cases. 
27. Neck sign was seen in 80% cases. 
28. One patient had calcinosis cutis. 
29. Malar rash was present in one patient. 
30. One patient had telengiectasia in both cheeks. 
31. Loss of hair in the extremities was seen in 50% cases. 
32. Hypohidrosis was seen in 65% cases. 
33. One patient had leg ulcer. 
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34.  Nail changes were present in 70% cases, most commonly ragged 
cuticles were present.  
35. Other associated skin conditions reported were psoriasis, tinea 
versicolor, dermatophytosis, plantar wart. 
36. Anaemia was present in 25% cases. 
37. Elevate ESR was present in 70%  patients. 
38. Gastrointestinal, respiratory and musculoskeletal involvement were 
common. 
39. Gastroesophageal refux was present in 85 % cases.  
40. Endoscopy showed oesophagitis in 40% and lax  gastroesophageal 
sphincter in 5% 
41. Dysphagia was present in 40% cases. 
42. Barium swallow studies showed dysmotility in 5% and narrowing of 
thoracic oesophagus in 5%. 
43. Three patients had altered bowel habits, in one patient diarrhea was 
the presenting complaint. 
44. Dyspnoea was present in 75% and dry cough in 35% 
45. ILD was present in 95% cases. 
46. Pulmonary function test showed restrictive pattern in 95%, of which 
it was mild in 20 % and moderate in 75% 
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47. One patient had pulmonary arterial hypertension. 
48. Arthralgia was present in 45% cases. 
49. One patient had overlap with Epidermolysis Bullosa Acquisita. 
50. One patient had  myositis, malar rash, arthralgia. U1RNP was 
positive and the diagnosis of MCTD was made. 
51. X ray of hands showed acral osteolysis in 75% cases and osteopenia 
in 25% cases. 
52. Acral osteolysis was present in 84.6% patients with Raynaud’s 
phenomenon and 83.3% patients with fingertip scars. 
53. No patient had renal involvement. 
54. Hypothyroidism was present in two cases.  
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CONCLUSION 
The incidence of Systemic sclerosis was 0.2 per dermatology cases. Female 
preponderance was present . It  most commonly occurs from second to fourth 
decade, youngest patient  being 10 years and the oldest being 53 years. 
Occupational exposure to harmful environmental factors like silica, solvents, 
pesticides, heavy metals in firework were present in more than half of the cases. 
Even though skin involvement was present in all cases, 20% of cases present only 
after systemic involvement. All the patients had diffuse involvement of skin. Only 
65%  patients had  Raynaud’s phenomenon, this is probably because of higher 
temperature present throughout the year in South India. 100 % of patients with  
Raynaud’s phenomenon had Round finger pad sign. Round finger pad sign was 
also present in 42% patients without Raynaud’s phenomenon. There was one case 
of overlap syndrome, who showed all features of  Mixed Connective Tissue 
Disease. An interesting case of systemic sclerosis with Epidermolysis Bullosa 
Acquisita was reported. Systemic involvement was seen in most cases, mainly 
involving the pulmonary, gastrointestinal system. Interstitial lung disease was 
present in 95% cases. No patient had renal involvement.  X ray of hands showed 
acral osteolysis and osteopenia and this correlated with Raynaud’s phenomenon 
and fingertip scars.  
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CLASSICAL SCLERODERMA FACIES – LOSS OF FOREHEAD 
WRINKLES, PINCHED NOSE, PURSED LIPS 
 
 
MALE PATIENT WITH MINIMAL INVOLVEMENT 
  
 
X RAY OF HANDS SHOWING ACRAL OSTEOLYSIS 
 
BARIUM SWALLOW SHOWING NARROWING                                      
OF THORACIC OESOPHAGUS 
 
HRCT  CHEST - INTERSTITIAL LUNG DISEASE 
 
 
HRCT CHEST - INTERSTITIAL LUNG DISEASE 
 
DIF – LINEAR AND GRANULAR DEPOSITS OF IgG,IgM,IgA,         
FIBRIN, C3 ALONG BASAL LAYER 
 
 
 
 
SALT SPLIT TECHNIQUE – LINEAR IgA AND C3 ALONG THE 
DERMAL SIDE 
 
 
IgG IgM 
fibrin C3
IgA C3 
TENSE, LINEAR  VESICLES AND BULLA WITH CLEAR FLUID 
AND EROSIONS IN THE BACKGROUND OF 
SCLERODERMATOUS SKIN OF EXTREMITIES 
                                                    
HISTOPATHOLOGY OF VESICLE SHOWING SUBEPIDERMAL 
BULLA WITHOUT INFILTRATE AND HYALINIZED 
COLLAGEN IN DERMIS 
 
CALCINOSIS CUTIS 
 
 
TELANGIECTASIA  
 
CASE OF MIXED CONNECTIVE TISSUE DISEASE                              
WITH MALAR RASH 
 
 
LOSS OF LEFT INDEX FINGER  
 
 
 
NAILS – RAGGED CUTICLES 
 
 
RACQUET NAILS 
 
 
EXTENSIVE SALT AND PEPPER PIGMENTATION 
 
 
SALT AND PEPPER PIGMENTATION – CLASSICAL SITE – 
RETROAURICULAR AREA 
 
SCLERODACTYLY WITH BEAKED NAILS 
 
 STELLATE FINGERTIP SCARS 
 
SCLERODERMA FACIES – PINCHED NOSE, RADIAL 
FURROWS AROUND MOUTH 
 
 
SCLERODACTYLY 
 
 
                                                  PROFORMA 
NAME: 
AGE/ SEX: 
OCCUPATION:                                             
ADDRESS & PHONE NO: 
 
HISTORY: 
PRESENTING COMPLAINT –                                          DURATION - 
TIGHTNESS OF SKIN 
DIFFICULTY IN MOUTH OPENING 
RAYNAUD’S PHENOMENON 
FINGERTIP ULCERS/ GANGRENE/ DIGIT LOSS 
LEG ULCER 
COUGH – TYPE 
DYSPNOEA 
 CHEST PAIN 
FATIGUE / MYALGIA / ARTHRALGIA  
PROXIMAL MUSCLE WEAKNESS 
DYSPHAGIA 
RETROSTERNAL BURNING / REGURGITATION 
BLOATING / CONSTIPATION / DIARRHOEA 
ABDOMINAL PAIN / GI BLEED 
PHOTOSENSITIVITY / RASH OVER FACE / ORAL EROSIONS / FEVER / 
SEIZURES 
OTHERS 
 
 
EXAMINATION: 
ANEMIA / JAUNDICE / PEDAL EDEMA / LYMPH NODES  
CVS- 
RS-               CREPTS, CHEST EXPANSION 
P/A- 
CNS- 
BP-                                 PULSE -  
D/E: 
HIDE BOUND SKIN – EXTENT – MODIFIED RODNAN SCORE 
SCLERODACTYLY 
PINCHED NOSE 
FISH MOUTH/ RADIAL FURROWS 
MACROGLOSSIA 
DIFFICULTY IN MOUTH OPENING 
DIFFICULTY IN RETRACTING LOWER EYELID 
STELLATE SCARS / FINGER TIP ULCERS 
DEMONSTRATION OF RAYNAUD’S PHENOMENON 
ROUND FINGER PAD SIGN 
NAILS – RAGGED CUTICLE / PTERYGIUM INVERSUM UNGUIS 
CALCINOSIS CUTIS 
SALT & PEPPER PIGMENTATION/ GENERALISED HYPERPIGMENTATION 
NECK SIGN 
LEG ULCER 
ATROPHIE BLANCHE / LIVEDO RETICULARIS 
LOSS OF HAIR / HYPO/ ANHYDROSIS 
MUSCLE POWER / MUSCLE TENDERNESS 
OTHERS 
INVESTIGATIONS: 
COMPLETE HEMOGRAM 
URINE ROUTINE 
RFT 
LFT 
CHEST X-RAY 
PFT 
HRCT 
ECG 
ECHO 
USG – ABDOMEN & PELVIS 
BARIUM SWALLOW 
ENDOSCOPY 
ANA, Scl 70 
X- RAY – HANDS & FEET 
OTHERS – EMG / MUSCLE BIOPSY / CPK/ SKIN BIOSY/DIF 
 
M
A
S
T
E
R
 C
H
A
R
T
                   KEY TO MASTER CHART 
a                    –    Arm 
ab                  –    abdomen 
Al polishing –     Aluminium polishing 
an                 –     anaemia 
ao                 –     acral osteolysis 
ar                  –     arthralgia 
c                   –     chest 
D                  –     Dysmotility 
DM              –     dermatomyositis 
dysp            –     dyspnoea 
E                 –     esophagitis 
f                  –     face 
F                 –     female 
f u               –     fingertip ulcer 
fa                –     forearm 
fe                –     feet 
fi                 -     finger  
GERD        –     gastro esophageal reflux disease 
h                 –     hand 
Hb              –     hemoglobin 
ILD            –      interstitial lung disease 
irce             –      increased renal cortical echoes 
l              –      leg 
L, RIF    –      left, right index finger 
Lax E     –      lax gastroesophageal sphincter 
LE          –      lupus erythematosus 
lm           –     longitudinal melanonychia 
LMF       –     left middle finger 
lwc         –      low voltage QRS complex 
M           –      male  
mod       –      moderate 
N           –      normal 
n            –      not present 
NE         –      narrowing of thoracic oesophagus 
o            –      osteopenia 
p            –      present 
p c         –       pigment change 
PAH      –       pulmonary arterial hypertension 
p-d         –       present, dry type 
pes         –       pesticides 
R           –       Raynaud’s phenomenon 
ra          –        retroauricular 
rc          –        ragged cuticles 
RC        –        renal calculi 
rq          –        racquet nails 
s             –      scalp 
s t           –      skin tightness 
sil           –      silica 
sol          –      solvents 
t              –      thigh 
t.c.          –      tinea corporis 
t.v.          –      tinea versicolor 
telangiec –      telangiectasia 
y              –      years 
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